Government to introduce plans for pushing bulk drug manufacturing capacities
New Delhi, February 18, 2015: The Government of India plans to introduce strategies to improve the bulk drug manufacturing capacity in the country. The move will help in reducing dependence on China for import of bulk drugs.
Currently India is importing close to 7—80 percent bulk drugs from China and will shortly come out with strategies to improve its bulk drug capacity, according to the Pharmaceuticals Secretary, Mr V K Subburaj. He also added that there was a time when India was producing bulk drugs in a way.
The committee set up by the government has already submitted its recommendations and the Department of Pharmaceuticals is examining it and will come up with a strategy shortly. The strategy will be a part of the proposed bulk drug pharma policy.
The government is also planning revive entities like Hindustan Antibiotics Ltd (HAL) and Indian Drugs and Pharmaceuticals Ltd (IDPL). In addition, the government is also discussing the issue with state governments like Telangana, Andhra Pradesh, Rajasthan and Madhya Pradesh to create bulk drug capacities.
It is expected that the dependence on China will reduce significantly in 10 years from now.